openPR Logo
Press release

What is Liposomal Vitamin C? | ONS & FSMP Guide

08-07-2025 06:02 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: ABNewswire

What Does "Liposomal" Mean? Understanding Liposomal Vitamin C.

Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-08/wechat_2025-08-06_015004_689.png

Modern supplements promise more than ever, yet many nutrients break down before your body can use them. SINOFN Health harnesses liposomal technology to protect vitamins like vitamin C in tiny phospholipid spheres-so they glide through digestion intact and deliver maximum potency.

How Liposomes Work

*
They encapsulate water-soluble nutrients at their core or embed fat-soluble compounds in their lipid layers.

*
When liposomes reach the small intestine, their membranes fuse with gut-cell walls, releasing the nutrient payload directly into circulation.

*
This fusion bypasses many digestive hurdles-acid, enzymes and transporter limits-so more of the active ingredient reaches its target.

Key Advantages of Liposomal Delivery

*
Superior Stability Phospholipid encapsulation shields delicate vitamins from oxidation, heat and light damage.

*
Enhanced Bioavailability Clinical studies show liposomal supplements can double or triple blood-level uptake compared to standard tablets.

*
Targeted Release Advanced formulations can be tailored for slow release or organ-specific delivery, optimizing support where it's needed most.

*
Gentler on Digestion The lipid envelope minimizes gastrointestinal discomfort, even at higher doses.

Bringing Liposomal Power into FSMP ONS

When clinical nutrition meets advanced delivery, patients benefit from both macro-nourishment and micro-targeted support. SINOFN Health now offers a line of Foods for Special Medical Purposes (FSMP) oral nutritional supplements (ONS) infused with liposomal vitamins and antioxidants. Each formula is engineered to satisfy energy and protein requirements while ensuring superior absorption of key micro-nutrients.

What Are FSMP ONS?

FSMP ONS are scientifically formulated liquids, semi-solids or powders designed for patients with specific medical or metabolic conditions that impede adequate nutrition from regular diets. Under healthcare supervision, they:

*
Provide complete or supplementary macro- and micronutrients

*
Address malnutrition, elevated protein needs, wound healing, or digestive impairments

*
Comply with EU FSMP regulations and national standards

Adding liposomal encapsulation to these blends elevates their efficacy by protecting sensitive vitamins through the digestive tract and delivering them directly to cells.

Why Liposomal FSMP ONS?

*
Enhanced Macro- and Micro-nutrition A balanced 250 mL serving delivers calories, protein and carbs, plus liposomes packed with vitamin C, glutathione or B12-bridging the gap between quantity and quality.

*
Superior Absorption Phospholipid spheres shield active ingredients from stomach acid and enzyme degradation, raising bioavailability above 80 %.

*
Targeted Clinical Support Customizable blends for wound-care, oncology nutrition, renal support or immune modulation allow precise nutritional therapy.

*
Gentle Tolerance Lipid envelopes reduce gastrointestinal side effects often seen with high-dose vitamins in conventional ONS.

Beyond Vitamin C: SINOFN's Liposomal Lineup

NUTRIENT
KEY BENEFIT

Liposomal Glutathione
Cellular antioxidant defense

Liposomal B12
Improved energy production and mood

Liposomal Curcumin
Enhanced anti-inflammatory support

Liposomal CoQ10
Cardiovascular health and vitality

*Discover the full range of liposomal supplements at SINOFN Health-including multivitamins, NAD+, quercetin and more.

How to Incorporate SINOFN FSMP ONS

*
Prescribe under HCP guidance

*
Start at 1-2 servings per day, titrate to target intake

*
Administer at room temperature, shake well before use

*
Store unopened bottles in a cool, dark place; refrigerate after opening and consume within 24 hours

Quality, Safety and Compliance

*
Manufactured in GMP-certified facilities

*
Third-party testing for heavy metals, microbial limits and liposome integrity

*
Full compliance with FSMP labeling and registration requirements

Conclusion

Liposomal delivery is more than a buzzword-it's a proven way to get the most from your supplements. By mimicking your own cell membranes, liposomes protect nutrients, boost absorption and support gentle digestion. SINOFN Health's liposomal vitamin C liquid brings these benefits together in one easy, effective formula.

Ready to elevate clinical nutrition? Explore the complete SINOFN FSMP ONS portfolio and request a brochure. Partner with us to deliver evidence-based, liposomal-enhanced oral nutrition solutions that redefine patient outcomes.

Media Contact
Company Name: Sinofn (Tianjin) Pharm-Tech Co., Ltd.
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=what-is-liposomal-vitamin-c-ons-fsmp-guide]
Phone: 022-24928910
Address:No. 60 Weiliu Road, Airport Zone
City: Tianjin, 300308
Country: China
Website: https://www.sinofnhealth.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What is Liposomal Vitamin C? | ONS & FSMP Guide here

News-ID: 4137500 • Views:

More Releases from ABNewswire

Acute Bacterial Skin and Skin-Structure Infection (ABSSSI) Market: Insights into Epidemiology, Treatments, and Key Companies | MicuRx, Basilea Pharmaceuticals, AbbVie, Cubist Pharmaceuticals LLC, Nabr
Acute Bacterial Skin and Skin-Structure Infection (ABSSSI) Market: Insights into …
As per secondary analysis, ABSSSI accounted for almost 870,000 hospital admissions in the United States in 2004 which represents an increase of almost 30% in the incidence of this diagnosis over a 4-year period. Emerging therapies for acute bacterial skin and skin-structure infections (ABSSSI), including DALVANCE (dalbavancin), ORBACTIV, MRX-4, ZEVTERA (ceftobiprole), and others, are anticipated to drive growth in the ABSSSI market in the coming years. DelveInsight has published a new report
Parainfluenza Virus Infection Market: Insights on Epidemiology, Treatments, and Key Companies | Ansun Biopharma, AlloVir
Parainfluenza Virus Infection Market: Insights on Epidemiology, Treatments, and …
The Parainfluenza Virus Infection Market is projected to witness consistent growth throughout the forecast period (2024-2034). The Parainfluenza Virus Infection Market Size in the 7MM is expected to increase, driven by increasing Incident population. Emerging therapies for Parainfluenza virus infection, including DAS181, ALVR106, and others, are expected to drive growth in the Parainfluenza virus infection market in the coming years. DelveInsight has released a new report titled "Parainfluenza Virus Infection - Market
Dup15q Syndrome Market: Insights into Epidemiology, Treatments, and Key Companies | Ovid Therapeutics, Takeda, Q-State Biosciences, Radius Health, Zogenix
Dup15q Syndrome Market: Insights into Epidemiology, Treatments, and Key Companie …
Dup15q syndrome is a neurogenetic condition caused by duplications on chromosome 15q11.2-13.1. It is marked by hypotonia, developmental delays, intellectual disability (ID), epilepsy, and autism spectrum disorder (ASD). The extent of developmental impairments can vary significantly based on the nature of the duplication and whether it originated from the mother or father. Emerging therapies for Dup15q syndrome, including Bexicaserin, UBE3A (ASO), and others, are anticipated to drive growth in the Dup15q
Narcolepsy Market: Insights into Epidemiology, Treatment Landscape, and Key Players | Alkermes, Avadel Pharmaceuticals, Axsome Therapeutics, Centessa Pharmaceuticals, Cephalon Inc., ConSynance Therape
Narcolepsy Market: Insights into Epidemiology, Treatment Landscape, and Key Play …
As per DelveInsight, the Narcolepsy Market is expected to expand at a healthy growth rate during the forecast period (2024-2034), owing to the launch of new therapies in the market and the rise in the number of cases. Emerging therapies for narcolepsy, including AXS-12 (reboxetine) and others, are anticipated to drive significant growth in the narcolepsy market over the coming years. DelveInsight has published a new report titled "Narcolepsy - Market Insights,

All 5 Releases


More Releases for Liposomal

Rising Prevalence Of Cancer Fuels Growth In Liposomal Doxorubicin Market: A Sign …
The Liposomal Doxorubicin Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Liposomal Doxorubicin Market Size and Projected Growth Rate? The liposomal doxorubicin market has also shown strong growth in recent years. It is expected to grow from $1.23 billion in 2024 to $1.32
Key Trend Reshaping the Liposomal Drug Delivery Devices Market in 2025: Strategi …
What industry-specific factors are fueling the growth of the liposomal drug delivery devices market? The global increase in cancer cases is expected to bolster the liposomal drug delivery devices market in the future. These delivery systems offer targeted treatments for cancer through radiation therapy, chemotherapy, and surgical resection. For example, data from UK-based charity, Macmillan Cancer Support, in June 2022, revealed a cancer prevalence of 3 million in 2022, which is
Liposomal Supplements Market Research Report 2023
Liposomal Supplements Market The global Liposomal Supplements market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-31J7848/Global_and_China_Liposomal_Supplements_Market_Insights_Forecast_to_2027 North American market for Liposomal Supplements is estimated to increase from $ million in 2023 to reach $ million by 2029,
Liposomal Supplements Market Research Report 2023 - valuates reports
The global Liposomal Supplements market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Liposomal Supplements is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of %
Liposomal Doxorubicin Market - Powerful Delivery, Enhanced Outcomes: Empowering …
Newark, New Castle, USA - new report, titled Liposomal Doxorubicin Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Liposomal Doxorubicin market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Liposomal Doxorubicin market. The report offers an overview of the market, which
Liposomal Market: Competitive Dynamics & Global Outlook 2024
New report published by Market Research Report Store (MRRS) which offers insights on the global Liposomal market. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/295025/global-liposomal-market Global Liposomal Market: Forecast by Type / Application / Region A liposome is a spherical vesicle having at least one lipid bilayer. The liposome can be used as a vehicle for administration of nutrients and pharmaceutical drugs. Liposomes can be prepared by disrupting biological membranes. The global